LATTICEFLOW-AI
1.2.2024 14:01:33 CET | Business Wire | Press release
LatticeFlow AI, the leading Artificial Intelligence (AI) platform for enabling enterprises to build performant, safe, and trustworthy AI systems at scale, today announced the appointment of Tom Ulrich as Senior Vice President and General Manager for North America. More recently, Tom served as Vice President of Sales, Financial Services at C3.AI, where he played a key role in launching the company’s AI banking business which led to a successful IPO in 2019 (NYSE:AI).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240201601542/en/
(Graphic: Business Wire)
Tom’s appointment follows LatticeFlow AI’s strategic expansion into the US market. With over 25 years of experience, Tom has proven expertise in building and developing world class sales teams for high-growth enterprise SaaS companies.
“Tom brings unmatched expertise in scaling early to mid-stage tech companies into hyper-growth phases. At LatticeFlow AI, Tom will play a vital role in accelerating our growth trajectory by identifying strategic business opportunities and driving revenue growth in the North American market,” said Petar Tsankov, CEO & Co-founder of LatticeFlow AI.
Earlier in his career, Tom held various sales leadership roles at MicroStrategy, where he helped grow the company from $20 million to $500 million, culminating in a successful IPO (NASDAQ:MSTR). Throughout his professional journey, Tom has remained steadfast in his dedication to helping clients unlock business value through data-driven insights.
"As AI becomes increasingly integral in our daily lives, ensuring model trust, safety, and a positive societal impact is more important than ever. I’m excited and honored to join the LatticeFlow AI team, collaborating with some of the best AI engineers in the world who are focused on tackling these challenges. I look forward to helping our customers harness the power of AI, while accelerating model performance and safety,” said Tom Ulrich.
“Tom joining LatticeFlow AI serves as yet another testimonial to the Company’s ability to attract world-class talent,” stated Andre Boisvert, Chairman of LatticeFlow AI. “Tom’s extensive experience in building global sales teams across five distinct enterprise software companies, with a particular focus on predictive analytics and AI, underscores his invaluable potential for propelling LatticeFlow AI's advancement.”
Tom received an MBA from George Washington University with a major in International Business and is based in Vienna, VA.
About LatticeFlow AI
Founded by world renowned AI researchers from ETH Zurich, LatticeFlow AI enables enterprise companies to develop production-ready machine learning models at scale. By systematically identifying and fixing model and data issues at scale, we help enterprises unlock the true potential of AI. Additionally, we offer a comprehensive technical AI assessment to assist enterprises achieve regulatory compliance, reliability and robustness for their mission-critical AI applications. LatticeFlow AI has won several awards including the AI Privacy Challenge in April 2023, followed by the Swiss AI Award and the US Army Global AI Award.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201601542/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom